A global clinical research organization increases its ability to create internal studies and make mid-study changes faster
BARCELONA, Spain, Nov. 9, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Excelya is using Vault EDC for electronic data capture (EDC), data cleansing and trial reporting. clinical. The full-service contract research organization (CRO) will benefit from faster database build cycles and zero downtime when making study design changes.
"Veeva's innovative technology and services have transformed our approach to managing complex clinical trials," said Géraldine Mercier, Global Head of Data Management at Excelya. "Our study teams appreciate how Veeva Vault EDC's drag-and-drop functionality and agile user acceptance testing make study design quick and easy."
Excelya is an independent, global CRO providing fully integrated design and execution of Phase I to IV clinical trials to pharmaceutical, biotech and medical device companies. By optimizing clinical data capture with Vault EDC, Excel now has a system to accelerate the design and execution of high-quality trials. Excelya is also leveraging Veeva RTSM for complete randomization and trial supply management, integrated with Vault EDC to further streamline data workflows.
"Effective data capture is key to conducting successful clinical trials," said Paul MacDonald, senior director of strategy for Veeva Vault CDMS. "Excelya's addition of Veeva Vault EDC is an important step in transforming its approach to data management, simplifying study creation and trial execution for faster new drug development."
Additional InformationFor more information about Veeva Vault EDC, visit: veeva.com/eu/VaultEDCConect with Veeva on LinkedIn: linkedin.com/company/veeva-systems Follow @veeva_eu on Twitter: twitter.com/veeva_eu
About Excelya
Excelya is an independent European contract research organization with more than 800 employees in 24 countries spread across Europe. Excelya offers all models of cooperation, from consulting to the provision of functional services and full service. It provides these research services in multiple sectors, such as pharmaceuticals, biotechnology, medical devices, cosmetics and nutrition. As a fully integrated CRO, Excelya handles the design and execution of phase I clinical trials through post-marketing, safety, biometrics, and market access projects. Excelya is committed to providing preeminent experts who work hand-in-hand with their clients to accelerate end-to-end drug development, harness data science, and reimagine patient care. www.excelya.com
About Veeva Systems
Veeva is the world leader in cloud software for the life sciences industry. Committed to innovation, product excellence and customer success, Veeva serves more than 1,000 customers, from the world's largest pharmaceutical companies to emerging biotech companies. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com/eu.
Veeva Forward-Looking Statements
This release contains forward-looking statements about Veeva's products and services and the expected results or benefits from the use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update any such statements. There are numerous risks that may adversely affect our results, including the risks and uncertainties set forth in our filing on Form 10-Q for the period ended July 31, 2022, which you can find here (see pages 39-40). you can find a summary of the risks that may affect our business), and in our subsequent filings with the SEC, which you can access at sec.gov.
Contact:
Jeremy WhittakerVeeva Systems 49-695-095-5486jeremy.whittaker@veeva.com
logo - link
View original content: enlace
